We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 15, 2021

Concentration-Dependent Importance of hs-cTnT in HFrEF and the Influence of Empagliflozin

European Journal of Heart Failure

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Heart Failure
Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR-Reduced Trial
Eur. J. Heart Fail 2021 May 30;[EPub Ahead of Print], M Packer, JL Januzzi, JP Ferreira, SD Anker, J Butler, G Filippatos, SJ Pocock, M Brueckmann, W Jamal, D Cotton, T Iwata, F Zannad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading